AG
TEVA icon

Artal Group’s Teva Pharmaceuticals TEVA Stock Holding History

Artal Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-450,000
Closed -$24.1M – 80
2016
Q1 		$24.1M Hold
450,000
– – 0.47% 18
2015
Q4 		$29.5M Hold
450,000
– – 0.55% 20
2015
Q3 		$25.4M Hold
450,000
– – 0.57% 28
2015
Q2 		$26.6M Sell
450,000
-150,000
-25% -$9.25M 1.14% 28
2015
Q1 		$37.4M Buy
600,000
+100,000
+20% +$5.81M 1.73% 17
2014
Q4 		$28.8M Sell
500,000
-100,000
-17% -$5.57M 1.01% 19
2014
Q3 		$32.3M Sell
600,000
-100,000
-14% -$5.3M 1.19% 15
2014
Q2 		$36.7M Buy
700,000
+100,000
+17% +$5.11M 1.48% 13
2014
Q1 		$31.7M Sell
600,000
-100,000
-14% -$4.62M 1.15% 19
2013
Q4 		$28.1M Hold
700,000
– – 1.01% 18
2013
Q3 		$26.4M Hold
700,000
– – 0.86% 15
2013
Q2 		$27.4M Buy
+700,000
New +$27.3M 0.86% 17

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return